Understanding the risks and benefits of policy action in NAFLD

被引:1
|
作者
Rowe, Ian A. [1 ,2 ]
机构
[1] St James Univ Hosp, Leeds Inst Data Analyt, Room 6-1,Level 6,Clin Sci Bldg,Beckett St, Leeds LS9 7TF, England
[2] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Data Analyt, Leeds, England
关键词
QUALITY-OF-LIFE; LIVER-DISEASE; COMPLICATIONS;
D O I
10.1016/j.jhep.2023.03.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:22 / 24
页数:3
相关论文
共 50 条
  • [41] A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
    Meckley, Lisa M.
    Gudgeon, James M.
    Anderson, Jeffrey L.
    Williams, Marc S.
    Veenstra, David L.
    PHARMACOECONOMICS, 2010, 28 (01) : 61 - 74
  • [42] On the sustained importance of attitudes toward technological risks and benefits in policy studies
    Jale Tosun
    Policy Sciences, 2017, 50 : 563 - 572
  • [43] Time to re-evaluate the risks and benefits of valproate and a call for action
    Howes, Oliver D.
    Barnes, Thomas R. E.
    Lennox, Belinda R.
    Markham, Sarah
    Natesan, Sridhar
    BRITISH JOURNAL OF PSYCHIATRY, 2022, 221 (06) : 711 - 713
  • [44] A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
    Lisa M. Meckley
    James M. Gudgeon
    Jeffrey L. Anderson
    Marc S. Williams
    David L. Veenstra
    PharmacoEconomics, 2010, 28 : 61 - 74
  • [45] Benefits and Risks of the Driving Restriction Policy: A Case Study of Xi'an, China
    Ma, Zhuanglin
    Cui, Shanshan
    Chien, Steven I-Jy
    Xiong, Ying
    IEEE ACCESS, 2020, 8 (08): : 99470 - 99484
  • [47] Risks and benefits
    Novack, GD
    OCULAR SURFACE, 2006, 4 (01): : 58 - 60
  • [48] RISKS AND BENEFITS
    HAGGERTY, LM
    HUMANE MEDICINE, 1987, 3 (01) : 71 - 71
  • [49] BENEFITS AND RISKS
    不详
    NATURE, 1973, 246 (5427) : 9 - 10
  • [50] RISKS AND BENEFITS
    TIPPEE, B
    OIL & GAS JOURNAL, 1981, 79 (25) : 15 - 15